Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a serious liver disorder associated with the accumulation of fat and inflammation. The objective of this study was to determine the gut microbiota composition that might influence the progression of NAFLD. Germ-free mice were inoculated with feces from patients with nonalcoholic steatohepatitis (NASH) or from healthy persons (HL) and then fed a standard diet (STD) or high-fat diet (HFD). We found that the epididymal fat weight, hepatic steatosis, multifocal necrosis, and inflammatory cell infiltration significantly increased in the NASH-HFD group. These findings were consistent with markedly elevated serum levels of alanine transaminase, aspartate transaminase, endotoxin, interleukin 6 (IL-6), monocyte chemotactic protein 1 (Mcp1), and hepatic triglycerides. In addition, the mRNA expression levels of Toll-like receptor 2 (Tlr2), Toll-like receptor 4 (Tlr4), tumor necrosis factor alpha (Tnf-α), Mcp1, and peroxisome proliferator-activated receptor gamma (Ppar-γ) significantly increased. Only abundant lipid accumulation and a few inflammatory reactions were observed in group HL-HFD. Relative abundance of Bacteroidetes and Firmicutes shifted in the HFD-fed mice. Furthermore, the relative abundance of Streptococcaceae was the highest in group NASH-HFD. Nevertheless, obesity-related Lactobacillaceae were significantly upregulated in HL-HFD mice. Our results revealed that the gut microbiota from NASH Patients aggravated hepatic steatosis and inflammation. These findings might partially explain the NAFLD progress distinctly was related to different compositions of gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To establish causality, transplantation of fecal microbiota from patients with MASLD or MASH induced steatosis and fibrosis in antibiotic-treated and germ-free mice (87, 202, 203).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [203]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gut Microbiota Is a Key Modulator of Insulin Resistance in TLR 2 Knockout Mice
Caricilli, A. M., Picardi, P. K., de Abreu, L. L., Ueno, M., Prada, P. O., Ropelle, E. R., Hirabara, S. M., Castoldi, Â., Vieira, P., Camara, N. O. S., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001212 · Cited by 282
RetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“Hence, colonization of GF mice with the “obesity-related microbiota” resulted in a significant increase in total body fat relative to GF mice colonized with a “thinness-related microbiota” [22].”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“In one study, Backhed and coworkers reported that the colonization of GF mice with microbiota from conventionally raised animals produces an increase in body fat [25].”
BackgroundObesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“Research has shown that the relative abundance of Bacteroidetes is lower and that of Firmicutes is higher in obese mice compared to their leaner counterparts [26].”
BackgroundGut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“Follow-up experiments involving human fecal samples from twins discordant for obesity (when transplanted into gnotobiotic mice) showed significant body composition differences [15].”
The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000322 · Cited by 3,058 · cited 3×
“The level of Bacteroidetes is significantly lower in obese subjects as compared with normal-weight subjects [13].”
BackgroundThe Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Cited by
Items 101–159 of 159
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link
Effenberger, M., Grander, C., Grabherr, F., & Tilg, H. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00069 · Cited by 17
Zhao, D., Wang, X., Liu, H., Su, M., Sun, M., Zhang, L., & Ye, H. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.02.044 · Cited by 15
Therapeutic manipulation of the microbiome in liver disease
Parthasarathy, G., Malhi, H., & Bajaj, J. S. (2024) · Hepatology · doi:10.1097/hep.0000000000000987 · Cited by 15
Backer, S., & Khanna, D. (2023) · Cureus · doi:10.7759/cureus.45231 · Cited by 13
Fei, N., Miyoshi, S., Hermanson, J. B., Miyoshi, J., Xie, B., DeLeon, O., Hawkins, M., Charlton, W., D’Souza, M., Hart, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.09.523249 · Cited by 10
Hu, Z., He, Z., Wang, Y., Chu, Z., Zhou, Y., Li, W., Lu, J., Lin, Q., & Luo, F. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2556470 · Cited by 16
Zhu, L., Li, D., & Yang, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1132026 · Cited by 10
Mechanisms underpinning the effect of exercise on the non-alcoholic fatty liver disease
Bekheit, M., Kamera, B. S., Colacino, L., Dropmann, A., Delibegović, M., Almadhoob, F., Hanafy, N. A. N., Bermano, G., & Hammad, S. (2025) · EXCLI journal · doi:10.17179/excli2024-7718 · Cited by 19
Huang, W.-W., Shen, B., Li, X., Zhang, T., & Zhou, X. Q. (2023) · Foods · doi:10.3390/foods12183393 · Cited by 9
Self-citationNonalcoholic Fatty Liver Disease: Changes in Gut Microbiota and Blood Lipids
Yang, K., Zeng, J., Wu, H., Liu, H., Ding, Z., Liang, W., Wu, L., Lin, Z., Huang, W., Xu, J., et al. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00199 · Cited by 9
Self-citationZhang, D., Xu, Y., Chen, H., Wang, D., Geng, Z., Chen, Y., Chen, Y., Xiong, D., Yang, R., Liu, X., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.993501 · Cited by 8
Self-citationColonic bacterial composition is sex-specific in aged CD-1 mice fed diets varying in fat quality
Unger, A. L., Eckstrom, K. M., Jetton, T. L., & Kraft, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226635 · Cited by 9
Chen, W., Liang, F., Zhang, Y., Zhang, Y., Lv, J., Jin, X., Ran, Y., Li, S., & Sun, W. C. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1449090 · Cited by 9
Basson, A. R., Cominelli, F., & Rodriguez‐Palacios, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030234 · Cited by 7
Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status
Kiseleva, Y. V., Maslennikov, R. V., Gadzhiakhmedova, A. N., Zharikova, T. S., Kalinin, D. V., & Zharikov, Y. O. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i2.208 · Cited by 8
Zhao, Y., Han, X., Wang, K., Fang, J. Q., Wang, Z., & Liu, G. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110708 · Cited by 6
Genome-Based Nutrition in Chronic Liver Disease
Román, S., Rivera‐Íñiguez, I., Ojeda‐Granados, C., Sepúlveda-Villegas, M., & Panduro, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814466-4.00001-x · Cited by 7
Patterns of 'Analytical Irreproducibility' in Multimodal DiseasesPreprint
Basson, A. R., Cominelli, F., & Rodriguez‐Palacios, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.22.002469 · Cited by 7
Hauser, G., Horvat, I. B., Rajilić-Stojanović, M. D., Zrnić, I. K., Kukla, M., Aljinović-Vučić, V., & Mikolašević, I. (2025) · Biomedicines · doi:10.3390/biomedicines13040779 · Cited by 10
Unrug-Bielawska, K., Sandowska-Markiewicz, Z., Pyśniak, K., Piątkowska, M., Czarnowski, P., Goryca, K., Mróz, A., Żeber‐Lubecka, N., Wójcik-Trechcińska, U., Bałabas, A., et al. (2025) · Genes & Nutrition · doi:10.1186/s12263-025-00772-x · Cited by 7
Yang, Z., Su, H., Chen, X., Ni, Z., Tao, H., Jiang, Y., & Peng, L. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105963 · Cited by 8
Mi, F., Guo, J., Zheng, W., Shen, J., & Ye, H. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1723128 · Cited by 5
Deciphering the role of dietary modifications and gut dysbiosis in Non-Alcoholic Fatty Liver Disease
Vachher, M., Kaur, K., Marothia, M., Burman, A., Deepanjana, & Bansal, S. (2025) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2025.200305 · Cited by 9
Prebiotic Effects of Chinese Herbal Polysaccharides on NAFLD Amelioration: The Preclinical Progress
Jiang, L.-Y., Kan, Y.-N., Yu, Z., Jian, B., Yao, S., Lv, L.-Y., & Liu, J. (2022) · Natural Product Communications · doi:10.1177/1934578x221124751 · Cited by 5
Self-citationGut Microbiota and Drug-Related Liver Injury: Challenges and Perspectives
Su, Y., Lü, N., Li, Q., Wen, H., Zhang, X. Q., & Zhang, M. (2023) · Advanced Gut & Microbiome Research · doi:10.1155/2023/5442597 · Cited by 6
Zhao, X., Li, R., Zhao, J., Sun, R., Zhang, S., Pan, Q., Lu, H., & Chai, J. (2025) · Medicine Bulletin · doi:10.1002/mdb2.70012 · Cited by 7
Epigenetic basis for environmentally induced liver disease
Chakraborty, S., Nath, J., Giri, A., & Bhandari, R. K. (2025) · Epigenetics Reports · doi:10.1080/28361512.2025.2586678 · Cited by 4
IGUDESMAN, D. A., Yu, G., Dauriat, C. J. G., Roman, T., Kashi, M. R., Blakley, E. A., Chassaing, B., & Corbin, K. D. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00381.2024 · Cited by 4
Fu, L., Huang, L., Gao, Y., Zhu, W., Cui, Y., Wang, S., Yan, M., Li, J., Duan, J., Pan, J., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-081293 · Cited by 6
Non-alcoholic fatty liver disease - opportunities for personalized treatment and drug development
Kemas, A. M., Youhanna, S. C., & Lauschke, V. M. (2022) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2022.2053285 · Cited by 5
The effects of fasting diets on nonalcoholic fatty liver disease
Mokhtari, Z., Hosseini, E., Hekmatdoost, A., Haskey, N., Gibson, D. L., & Askari, G. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac092 · Cited by 4
Implications of microbe-mediated crosstalk in the gut: Impact on metabolic diseases
Beg, R., Gonzalez, K., & Martinez, K. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159180 · Cited by 4
Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus
Xu, J., Wu, L., Deng, J., Yang, L., Wang, Y., Tian, H., Ji, Y., Xia, Q., Han, Z., Cheng, Y., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01433-z · Cited by 3
MAFLD under the lens: the role of gut microbiota
Sousa, P., & Machado, M. V. (2022) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2022.15 · Cited by 3
Crawford, M. S., Mohr, A. E., & Sweazea, K. L. (2020) · Journal of Nutrition and Metabolism · doi:10.1155/2020/8846401 · Cited by 3
Gut microbiota and bile acids changes in MASLD mice model with hepatic PLD1 knockout
Zhao, Y., Wang, H., Lin, W., Wang, H., & Cao, L. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025183 · Cited by 2
Liang, Y., Zhou, S., Chen, X., Yu, L., Zhang, D., & Lin, C. (2021) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000545 · Cited by 2
Lee, Y.-P., Chiu, C.-C., Chen, Y.-H., Huang, W.-C., Wang, Y., Chiu, C., Lin, T.-J., Hung, S.-W., Liu, J.-Y., & Chuang, H.-L. (2021) · Processes · doi:10.3390/pr9030434 · Cited by 2
Self-citationWu, C., & Tseng, C. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_5 · Cited by 2
Ткач, С. М., Dorofeyev, A., Kuzenko, I., Boyko, N., Falalyeyeva, T. M., & Kobyliak, N. M. (2023) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-031-19564-8_10 · Cited by 3
Colon: a likely middleman connecting the liver, adipose tissue, and gut microbiota in MASLD
Priyadarshini, M., & Layden, B. T. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00248.2025 · Cited by 1
Xiang, G. A. O., Dai, S., Li, J., Wang, T., Sun, X., & Li, P. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01165-3 · Cited by 1
Chen, L., Xiang, H., Hua, X., Liu, Y., Liu, G., Fang, J., & Ding, S. (2026) · Food Reviews International · doi:10.1080/87559129.2026.2715569 · Cited by 1
Priyadi, H., Trimurtini, I., & Pontjosudargo, F. A. (2022) · doi:10.2991/978-94-6463-060-2_19 · Cited by 1
Microbiote intestinal et stéatopathie métabolique
Cassard, A., Houron, C., & Ciocan, D. M. (2020) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2019.12.002
Pontjosudargo, F. A., Priyadi, H., Sovia, E., Halima, L. S., & Septiadi, E. (2021) · Advances in health sciences research/Advances in Health Sciences Research · doi:10.2991/ahsr.k.210723.050
Fat Absorption, Metabolism, and Global Regulation
Rana, N., Mozaffari, P., Asim, D., & Martinez, K. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160950-00068
Ruissen, M. M., Keller, J. J., & Tushuizen, M. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822186-0.00010-9
冯, 琳. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1441127
Associations of Fecal Microbiota with Ectopic Fat in African Caribbean Men
Tilves, C., Mueller, N. T., Zmuda, J. M., Kuipers, A. L., Methé, B. A., Li, K., Carr, J. J., Terry, J. G., Wheeler, V. W., Nair, S., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12040812
The Role of the Intestinal Microbiota in NAFLD Onset and Progression
Pinheiro, I. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007741
Fecal microbiota transplantation alleviates high-fat and high-sugar diet-induced fatty liver in micePreprint
Mi, F., Guo, J., Zheng, W., & Ye, H. (2025) · Research Square · doi:10.21203/rs.3.rs-6242383/v1
Cheng, Y., Yang, Y., Guo, Y., Shi, Y., Feng, J., Jiang, X., Yang, Z., Zhu, H., & Liu, X. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02622-0
Implications du microbiote intestinal et de la pectine dans la stéato-hépatite non-alcoolique
Houron, C. (2020) · theses.fr (ABES) · doi:10.70675/282e9d85z4f3dz4f5bz9045zd1ce6da72037
Implication des micro-organismes producteurs d'éthanol dans la stéatohépatite non alcoolique
Mbaye, B. (2023) · theses.fr (ABES) · doi:10.70675/c4be8001zff46z4074za120z06a52c2feac7
Gut microbiota and treatment response heterogeneity across pharmacological therapies for MASH
Yan, P., Cai, S., & Xia, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1968956
Metadata
- Authors
- Chiu, C.-C., Ching, Y.-H., Li, Y.-P., Liu, J.-Y., Huang, Y.-T., Huang, Y.-W., Yang, S.-S., Huang, W.-C., & Chuang, H.-L.
- Affiliations
- Agricultural Technology Research Institute (TW)
- Tzu Chi University (TW)
- National Chung Hsing University (TW)
- National Institutes of Applied Research (TW)
- Cathay General Hospital (TW)
- National Taipei University of Nursing and Health Science (TW)
- Corresponding author
- Huang, Wen-Ching
- Chuang, Hsiao-Li
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2017-11-06
- Volume
- 9
- Issue
- 11
- Pages
- 1220
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC5707692
- OpenAlex
- W2765713881
- Cited by
- 160
- References
- 59
- Citations by year
- 2026: 5 · 2025: 18 · 2024: 18 · 2023: 24 · 2022: 21 · 2021: 22 · 2020: 27 · 2019: 15 · 2018: 10
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Science and Technology (MOST) of Taiwan (MOST 106-2319-B-492-001, NSC 100-2320-B-492-001-, NSC 101-2320-B-492-001-MY3, MOST 106-2410-H-227-007-)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, gut microbiota, high-fat diet, gnotobiotic mice, fecal microbiota transplantation, hepatic steatosis, liver inflammation, Toll-like receptors, Bacteroidetes, Firmicutes, Streptococcaceae, Lactobacillaceae, endotoxin, interleukin-6, MCP-1, TNF-α, PPARγ
- MeSH terms
- Gastrointestinal Microbiome, Adipose Tissue, Animals, Germ-Free Life, Humans, Liver, Male, Mice, Inbred C57BL, Mice, Diet, High-Fat, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.